As PDGFRα can also be activated by PDGF-AA in WAT (110), these findings suggest caution on specificity of adipocyte progenitor subset activation is required when designing therapeutics manipulating PDGFRα signaling to treat obesity and diabetes. The gene discussed is PDGFRA; the disease is Obesity.